Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RITUXIMAB-ABBS for Dermatomyositis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 56 adverse event reports in the FDA FAERS database where RITUXIMAB-ABBS was used for Dermatomyositis.

Most Reported Side Effects for RITUXIMAB-ABBS

Side Effect Reports % Deaths Hosp.
Off label use 2,167 49.9% 125 256
Intentional product use issue 273 6.3% 77 124
Dyspnoea 208 4.8% 65 104
Pain 205 4.7% 60 102
Rheumatoid arthritis 202 4.7% 64 109
Intentional dose omission 196 4.5% 14 76
Fatigue 195 4.5% 60 94
Drug ineffective 186 4.3% 59 73
Hypertension 183 4.2% 64 99
Infusion related reaction 183 4.2% 55 76
Rash 183 4.2% 51 102
Pyrexia 180 4.1% 50 119
Nausea 170 3.9% 36 74
Death 167 3.8% 167 19
Headache 167 3.8% 65 78

Other Indications for RITUXIMAB-ABBS

Rheumatoid arthritis (820) Product used for unknown indication (373) Diffuse large b-cell lymphoma (288) Immune thrombocytopenia (235) Vasculitis (151) B-cell lymphoma (133) Systemic lupus erythematosus (129) Mantle cell lymphoma (123) Multiple sclerosis (120) Non-hodgkin's lymphoma (111)

Other Drugs Used for Dermatomyositis

RITUXIMAB (993) METHOTREXATE (958) HUMAN IMMUNOGLOBULIN G (913) PREDNISONE (744) PREDNISOLONE (652) METHYLPREDNISOLONE (647) MYCOPHENOLATE MOFETIL (636) TACROLIMUS (626) CYCLOPHOSPHAMIDE (511) HYDROXYCHLOROQUINE (419)

Related Pages

RITUXIMAB-ABBS Full Profile All Dermatomyositis Drugs RITUXIMAB-ABBS Demographics RITUXIMAB-ABBS Timeline